Patent · US Active

Heteroarylamide inhibitors of TBK1

US9994547B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Simone Bigi · San Diego, US
Walter Keung · Encinitas, US
Steve Swann · San Diego, US
Phong Vu · San Diego, US
Steven John Woodhead · San Diego, US
Anthony R. Gangloff · San Diego, US

Key dates

Filing date	Oct 2, 2015
Grant date	Jun 12, 2018
Priority date	—
Expiry date	Oct 2, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds of formula 1: which are useful as inhibitors of TBK1. Also disclosed are pharmaceutical compositions which contain the compounds, methods for treatment of conditions associated with TBK1, and processes for making the compounds and intermediates thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.